{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:24:47Z","timestamp":1777433087423,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University","doi-asserted-by":"publisher","award":["D106-35A13"],"award-info":[{"award-number":["D106-35A13"]}],"id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejphar.2018.12.005","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T12:53:40Z","timestamp":1544100820000},"page":"95-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Parecoxib, a selective blocker of cyclooxygenase-2, directly inhibits neuronal delayed-rectifier K+ current, M-type K+ current and Na+ current"],"prefix":"10.1016","volume":"844","author":[{"given":"Yuan-Yuarn","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Tsung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey Chi-Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5247-1678","authenticated-orcid":false,"given":"Yen-Chin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.12.005_bib1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0896-6273(95)90185-X","article-title":"Modulation of K+ current by frequency and external [K+]: a tale of two inactivation mechanisms","volume":"15","author":"Baukrowitz","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2018.12.005_bib2","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ajog.2004.05.006","article-title":"A clinical trial demonstrates the analgesic activity of intravenous parecoxib sodium compared with ketorolac or morphine after gynecologic surgery with laparotomy","volume":"191","author":"Bikhazi","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0079-6107(00)00004-3","article-title":"Modulation and genetic identification of the M channel","volume":"73","author":"Brown","year":"2000","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/bja\/aep107","article-title":"Dexmedetomidine, an \u03b12-adrenergic agonist, inhibits neuronal delayed-rectifier potassium current and sodium current","volume":"103","author":"Chen","year":"2009","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2018.12.005_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.tins.2004.02.012","article-title":"Presynaptic K+ channels: electrifying regulators of synaptic terminal excitability","volume":"27","author":"Dodson","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2018.12.005_bib6","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1476-5381.2011.01483.x","article-title":"Characteristics and molecular basis of celecoxib modulation on K(v)7 potassium channels","volume":"164","author":"Du","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib7","doi-asserted-by":"crossref","first-page":"11652","DOI":"10.1523\/JNEUROSCI.2490-06.2006","article-title":"Broad-spectrum effects of 4-aminopyridine to modulate amyloid beta1-42-induced cell signaling and functional responses in human microglia","volume":"26","author":"Franciosi","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.12.005_bib8","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1074\/jbc.M708100200","article-title":"Inhibition of delayed rectifier potassium channels and induction of arrhythmia: a novel effect of celecoxib and the mechanism underlying it","volume":"283","author":"Frolov","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.12.005_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13104-015-1023-1","article-title":"Evidence of more ion channels inhibited by celecoxib: KV1.3 and L-type Ca2+ channels","volume":"8","author":"Frolov","year":"2015","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.ejphar.2018.12.005_bib10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1185\/030079905X56367","article-title":"Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?","volume":"21","author":"Hersh","year":"2005","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejphar.2018.12.005_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12868-014-0135-1","article-title":"Ability of naringenin, a bioflavonoid, to activate M-type potassium current in motor neuron-like cells and to increase BKCa-channel activity in HEK293T cells transfected with alpha-hSlo subunit","volume":"15","author":"Hsu","year":"2014","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejphar.2018.12.005_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1017\/S1461145707008346","article-title":"The synergistic inhibitory actions of oxcarbazepine on voltage-gated sodium and potassium currents in differentiated NG108-15 neuronal cells and model neurons","volume":"11","author":"Huang","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib13","first-page":"37","article-title":"Experimental and simulation studies on the mechanisms of levetiracetam-mediated inhibition of delayed-rectifier potassium current (KV3.1): contribution to the firing of action potentials","volume":"60","author":"Huang","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1177\/00912700122012607","article-title":"A pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects","volume":"41","author":"Karim","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib15","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11064-007-9334-9","article-title":"Enhancement of sodium current in NG108-15 cells during neural differentiation is mainly due to an increase in NaV1.7 expression","volume":"32","author":"Kawaguchi","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2018.12.005_bib16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.neuro.2011.05.011","article-title":"The neurological safety of epidural parecoxib in rats","volume":"32","author":"Kim","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2018.12.005_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2017.12.004","article-title":"The comprehensive electrophysiological study of curcuminoids on delayed-rectifier K+ currents in insulin-secreting cells","volume":"819","author":"Kuo","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/11317570-000000000-00000","article-title":"Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial","volume":"29","author":"Langford","year":"2009","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ejphar.2018.12.005_bib19","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.neuropharm.2008.01.009","article-title":"Characterization of aconitine-induced block of delayed rectifier K+ current in differentiated NG108-15 neuronal cells","volume":"54","author":"Lin","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.12.005_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00210-008-0353-0","article-title":"Tramadol-induced block of hyperpolarization-activated cation current in rat pituitary lactotrophs","volume":"379","author":"Liu","year":"2009","journal-title":"Naunyn Schmiede. Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jss.2017.11.012","article-title":"Parecoxib's effects on anastomotic and abdominal wound healing: a randomized Controlled trial","volume":"223","author":"Martinou","year":"2018","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejphar.2018.12.005_bib22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.clpt.6100304","article-title":"Intravenous parecoxib rapidly leads to COX-2 inhibitory concentration of valdecoxib in the central nervous system","volume":"83","author":"Mehta","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2018.12.005_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.conb.2008.08.017","article-title":"Sensory neuron voltage-gated sodium channels as analgesic drug targets","volume":"18","author":"Momin","year":"2008","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.pain.2008.08.010","article-title":"Antinociceptive effect of resveratrol in carrageenan-evoked hyperalgesia in rats: prolonged effect related to COX-2 expression impairment","volume":"140","author":"Pham-Marcou","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.12.005_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.expneurol.2010.03.014","article-title":"The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy","volume":"224","author":"Polascheck","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0166-2236(00)01892-0","article-title":"Kv3 channels: voltage-gated K+ channels designed for high-frequency repetitive firing","volume":"24","author":"Rudy","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2018.12.005_bib27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.mcn.2006.07.006","article-title":"Properties and expression of Kv3 channels in cerebellar Purkinje cells","volume":"33","author":"Sacco","year":"2006","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.ejphar.2018.12.005_bib28","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1523\/JNEUROSCI.19-18-07742.1999","article-title":"Two types of K(+) channel subunit, Erg1 and KCNQ2\/3, contribute to the M-like current in a mammalian neuronal cell","volume":"19","author":"Selyanko","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.12.005_bib29","doi-asserted-by":"crossref","first-page":"11453","DOI":"10.1073\/pnas.0702041104","article-title":"Selective control of cortical axonal spikes by a slowly inactivating K+ current","volume":"104","author":"Shu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2018.12.005_bib30","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/bja\/aeu411","article-title":"Postoperative pain after laparoscopic cholecystectomy is not reduced by intraoperative analgesia guided by analgesia nociception index (ANI(R)) monitoring: a randomized clinical trial","volume":"114","author":"Szental","year":"2015","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2018.12.005_bib31","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1021\/jm000069h","article-title":"N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: a potent and selective inhibitor of COX-2 for parenteral administration","volume":"43","author":"Talley","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2018.12.005_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.biosystems.2006.05.016","article-title":"Quantifying noise-induced stability of a cortical fast-spiking cell model with Kv3-channel-like current","volume":"89","author":"Tateno","year":"2007","journal-title":"Biosystems"},{"key":"10.1016\/j.ejphar.2018.12.005_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainresbull.2009.05.009","article-title":"Lack of correlation between the central anti-nociceptive and peripheral anti-inflammatory effects of selective COX-2 inhibitor parecoxib","volume":"80","author":"Urdaneta","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2018.12.005_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn1857","article-title":"Channel, neuronal and clinical function in sodium channelopathies: from genotype to phenotype","volume":"10","author":"Waxman","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2018.12.005_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1054\/jpai.2002.123652","article-title":"Adverse events associated with postoperative opioid analgesia: a systematic review","volume":"3","author":"Wheeler","year":"2002","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2018.12.005_bib36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jtbi.2008.01.031","article-title":"Contribution of slowly inactivating potassium current to delayed firing of action potentials in NG108-15 neuronal cells: experimental and theoretical studies","volume":"252","author":"Wu","year":"2008","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib37","doi-asserted-by":"crossref","first-page":"148403","DOI":"10.1155\/2012\/148403","article-title":"Evidence for inhibitory effects of flupirtine, a centrally acting analgesic, on delayed rectifier K+ currents in motor neuron-like cells","volume":"2012","author":"Wu","year":"2012","journal-title":"Evid. Based Complement Altern. Med."},{"key":"10.1016\/j.ejphar.2018.12.005_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s002320010028","article-title":"Characterization of ATP-sensitive potassium channels functionally expressed in pituitary GH3 cells","volume":"178","author":"Wu","year":"2000","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib39","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0028-3908(01)00114-9","article-title":"Rutaecarpine-induced block of delayed rectifier K+ current in NG108-15 neuronal cells","volume":"41","author":"Wu","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.12.005_bib40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jcp.20866","article-title":"Potent stimulation of large-conductance Ca2+-activated K+ channels by rottlerin, an inhibitor of protein kinase C-\u03b4, in pituitary tumor (GH3) cells and in cortical neuronal (HCN-1A) cells","volume":"210","author":"Wu","year":"2007","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.ejphar.2018.12.005_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08941939.2017.1423423","article-title":"The investigation of the Cox-2 selective inhibitor parecoxib effects in spinal cord injury in rat","author":"Yuksel","year":"2018","journal-title":"J. Investig. Surg."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918307027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918307027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T06:37:54Z","timestamp":1565246274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918307027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":41,"alternative-id":["S0014299918307027"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.005","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parecoxib, a selective blocker of cyclooxygenase-2, directly inhibits neuronal delayed-rectifier K+ current, M-type K+ current and Na+ current","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}